Ajinomoto Cambrooke, Inc. formerly Cambrooke Therapeutics, Inc. (expansion of Cambrooke Foods) was founded in 2000 by Lynn and David Paolella, the parents of two children diagnosed with a rare disease called phenylketonuria (PKU). PKU is one of the few genetic diseases, which is managed almost entirely with nutritional intervention. The Paolellas’ goal in forming Cambrooke was simple - to develop improved nutritional therapeutic options for those with serious medical disorders.

Today, Cambrooke produces medical formulas and foods for the management of a variety of medical conditions and we are continually innovating new nutritional options targeted at a wide array of diseases.

Ajinomoto Cambrooke, Inc. - Leaders in Therapeutic Medical Nutrition.

Cambrooke was the first medical foods company to launch a natural intact protein for the dietary management of phenylketonuria called Glytactin™ (modified glycomacropeptide).

Cambrooke collaborates with academia and industry partners to transform early phase development projects in therapeutic nutrition into viable commercial products.

Cambrooke employs scientific experts in the development, manufacturing and commercialization of nutritional therapeutics for patients with rare diseases.

Cambrooke’s products are supported by clinical evidence for the nutritional management of medical needs before they are selected for commercialization.

Cambrooke believes that both large and small patient populations are important when it comes to complex nutritional requirements.

Therapeutics

Ajinomoto Cambrooke, Inc.

Howard Lossing

Paula Richard

Stéphanie Lemay

Stephanie Lasher

Sarah Ripley

Leon Brooks

Dawn Mahoney

Susan Gingrich

Cindy Coffin

Natasha Raimondo Ms, Rd, Ld

Valerie Barbieri

Emily Sue Orrick Rdn, Ld

Manoj Nair

Margot B.

The Design and Creative team at Ajinomoto Cambrooke, Inc. is responsible for developing visually compelling and informative materials that effectively communicate the company's innovative nutritional therapeutic solutions. This team creates marketing collateral, product packaging, digital content, and global promotional assets to enhance brand identity and support the commercial success of products designed for managing rare medical conditions.

Design and Creative

Client Services and Support

Quality and Regulatory Affairs

��

Design and Creative

About

Team members

Other teams at Ajinomoto Cambrooke, Inc.

Client Services and Support

Quality and Regulatory Affairs

��������

Design and Creative

About

Team members

Other teams at Ajinomoto Cambrooke, Inc.

Client Services and Support

Quality and Regulatory Affairs

��